Seven Eight Capital’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-41,120
Closed -$1.02M 862
2024
Q1
$1.02M Sell
41,120
-15,826
-28% -$471K 0.11% 299
2023
Q4
$2.07M Buy
+56,946
New +$2.19M 0.24% 118
2021
Q4
Sell
-14,800
Closed -$1.05M 631
2021
Q3
$1.05M Buy
+14,800
New +$919K 0.1% 291
2016
Q1
Sell
-1,200
Closed -$82K 657
2015
Q4
$82K Buy
+1,200
New +$72.4K 0.06% 386

Other funds holding PRTA

Seven Eight Capital's PRTA Position: Q2 2024 in Review

Seven Eight Capital sold out of Prothena Corp (PRTA) in Q2 2024, closing a stake of 41,120 shares — an estimated $1.02M sold.

Seven Eight Capital first reported a position in PRTA in Q4 2015 and held it in 4 quarters. The position peaked at $2.07M in Q4 2023. 160 funds tracked by Wall St. Rank hold PRTA as of Q2 2024.

  • Seven Eight Capital reported no remaining Prothena Corp position as of Q2 2024 after selling out during the quarter.
  • Seven Eight Capital sold 41,120 Prothena Corp shares in Q2 2024, an estimated $1.02M.
  • Seven Eight Capital first reported a position in Prothena Corp in Q4 2015 and held it in 4 quarters.
  • Seven Eight Capital's Prothena Corp position peaked at $2.07M in Q4 2023.
  • 160 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2024.

Based on Seven Eight Capital's 13F filing for Q2 2024, filed 12 Aug 2024.